April 24, 2024
Salim Yusuf to receive honorary degree from Oxford University
Salim Yusuf will receive an honorary doctorate from Oxford University in recognition of his transformative contributions to cardiovascular disease (CVD)...
Read MoreApril 24, 2024
Salim Yusuf will receive an honorary doctorate from Oxford University in recognition of his transformative contributions to cardiovascular disease (CVD)...
Read MoreApril 9, 2024
A recent study has found that tranexamic acid (TXA), commonly used to reduce bleeding during cardiac surgery, failed to reduce...
Read MoreApril 8, 2024
A large international study has revealed that avoiding the use of benzodiazepine, a medication used for nearly 90% of patients...
Read MoreFebruary 28, 2024
A new trial will test a low-cost antibiotic in reducing deaths among 8,000 patients with advanced HIV who are starting...
Read MoreFebruary 20, 2024
Around 100 medical professionals recently gathered for the 25th edition of the Arrhythmia Update conference (AU24*) presented by PHRI on...
Read MoreFebruary 1, 2024
PHRI Scientist Maura Marcucci has received a multi-year grant from the Canadian Institutes of Health Research (CIHR) for the NeuroVISION-2...
Read MoreJanuary 30, 2024
Researchers at PHRI have received Health Canada approval for a nationwide clinical trial to test a new treatment for a...
Read MoreJanuary 29, 2024
PHRI Scientist Marie Pigeyre has been awarded the Canadian Institute for Health Research (CIHR) Operating Grant for the “Canadian Alliance...
Read MoreJanuary 22, 2024
Join us for the 25th edition of the Arrhythmia Update conference (AU24) on February 15th and 16th, as we bring...
Read MoreJanuary 4, 2024
PHRI is excited to announce the winners of its 2023 internal grant competition, celebrating ten early career researchers who have...
Read MoreDecember 13, 2023
The first participant in a large, global trial led by PHRI has undergone the implantation of a left atrial appendage...
Read MoreDecember 1, 2023
The Clinical Research Laboratory and Biobank- Genetic and Molecular Epidemiology Laboratory (CRLB-GMEL) recently hosted the Second Annual Multiomics Day at...
Read MoreDecember 1, 2023
PHRI’s Executive Director and Senior Scientist Salim Yusuf, Senior Scientist John Eikelboom, Senior Scientist Stuart Connolly, and Associate Senior Scientist Paul...
Read MoreNovember 13, 2023
The widely available blood thinner apixaban substantially reduced stroke in at-risk patients with a type of atrial fibrillation only detectable...
Read MoreNovember 6, 2023
On November 1st the PHRI research community gathered for the Perioperative Care Lectureship Event, featuring the esteemed Dr. Christian Mueller,...
Read MoreBack To Top